Analysis of the Effect of Crossover from Placebo (PBO) to Darolutamide (DARO) on Overall Survival (OS) Benefit in the ARAMIS Trial.
Journal of clinical oncology(2021)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined